Discordance With Local Guidelines for Adjuvant Chemotherapy in Breast Cancer: Reasons and Effect on Survival
- 1 February 2011
- journal article
- Published by Elsevier BV in Clinical Breast Cancer
- Vol. 11 (1), 46-51
- https://doi.org/10.3816/cbc.2011.n.008
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal studyBreast Cancer Research and Treatment, 2010
- Management of Operable Invasive Breast Cancer in Women Over the Age of 70: Long-Term Results of a Large-Scale Single-Institution ExperienceAnnals of Surgical Oncology, 2010
- Lost Opportunities: Physicians' Reasons and Disparities in Breast Cancer TreatmentJournal of Clinical Oncology, 2007
- Compliance With Consensus Recommendations for Systemic Therapy Is Associated With Improved Survival of Women With Node-Negative Breast CancerJournal of Clinical Oncology, 2004
- The difference between study recommendations, stated policy, and actual practice in a clinical trialAnnals of Oncology, 2004
- Adjuvant systemic therapies in women with breast cancer:an audit of clinical practice in ItalyAnnals of Oncology, 2003
- Physicians’ Reasons for Failing to Deliver Effective Breast Cancer CareMedical Care, 2003
- Discrepancy between Consensus Recommendations and Actual Community Use of Adjuvant Chemotherapy in Women with Breast CancerAnnals of Internal Medicine, 2003
- Correlation between MIB‐1 and other proliferation markersCancer, 2002
- Impact of breast cancer treatment guidelines on surgeon practice patterns: Results of a hospital-based interventionSurgery, 2000